Pharmacogenetics of RAS-affecting AGT and ACE variants and the efficacy of Valsartan/HCTZ therapy.

Saved in:
Bibliographic Details
Title: Pharmacogenetics of RAS-affecting AGT and ACE variants and the efficacy of Valsartan/HCTZ therapy.
Authors: Baig A; Department of Pharmacy, University of Swabi, Swabi, Pakistan., Shah SMM; Department of Pharmacy, University of Swabi, Swabi, Pakistan., Alfaiz AS; Internal Medicine Department, Shaqra College of Medicine, Shaqra University, Shaqra, Saudi Arabia., Alammar MA; Family Medicine, Shaqra Collage of Medicine, Shaqra University, Shaqra, Saudi Arabia., Alotaibi MDG; Internal Medicine Department, Shaqra College of Medicine, Shaqra University, Shaqra, Saudi Arabia., Rauf A; Department of Pharmacy, Abdul Wali Khan University, Mardan, Pakistan., Begum A; Department of Pharmacy, University of Peshawar, Peshawar, Pakistan., Hassan ZU; Cardiology Ward, Hayat Medical Complex Hospital, Peshawar, Pakistan., Ainy N; Institute of Radiotherapy and Nuclear Medicine (IRNUM), Peshawar, Pakistan., Babaresh WM; Faculty of Pharmacy, University of Aden, Aden, Yemen. wahbi.mohammed.pharm@aden-univ.net., Zakiullah; Department of Pharmacy, University of Peshawar, Peshawar, Pakistan. zakiullah@uop.edu.pk.
Source: Scientific reports [Sci Rep] 2026 Mar 07; Vol. 16 (1). Date of Electronic Publication: 2026 Mar 07.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first